103 | A PHASE 1 STUDY OF KITE‐363 ANTI‐CD19/CD20 CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) B‐CELL LYMPHOMA.
Saved in:
| Title: | 103 | A PHASE 1 STUDY OF KITE‐363 ANTI‐CD19/CD20 CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) B‐CELL LYMPHOMA. |
|---|---|
| Authors: | Dahiya, S., Ulrickson, M. L., Topp, M. S., Kersten, M. J., Yared, J., Reagan, P. M., Reshef, R., Sanderson, R., Voorhees, T., Ahmed, S., Jung, A. S., Granados, E., Dong, J., Winters, J., Kanska, J., Nahas, M., Nastoupil, L. |
| Source: | Hematological oncology 2025 Supplement; Vol. 43. |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 0278-0232 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
